BioCentury
ARTICLE | Financial News

Amgen down after earnings report

October 27, 2000 7:00 AM UTC

AMGN was off $9.188 (13 percent) to $59.313 on Friday following Thursday's after market earnings announcement in which the biotech bellwether said that it now expects EPS for the year to be at the low...